share_log

CVS Health | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.3%)

CVS Health | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.3%)

西維斯健康 | SC 13G/A:超過5%持股股東披露文件(修正)-BlackRock, Inc.(8.3%)
美股SEC公告 ·  10/25 04:49

牛牛AI助理已提取核心訊息

BlackRock, Inc., a major investment management corporation based in Delaware, has filed an amended Schedule 13G with the Securities and Exchange Commission on September 30, 2024, indicating a significant ownership stake in CVS Health Corporation. The filing reveals that BlackRock now beneficially owns 104,561,659 shares of CVS Health, which represents 8.3% of the company's common stock. This position gives BlackRock sole voting power over 93,976,550 shares and sole dispositive power over the entire 104,561,659 shares held. The filing underscores BlackRock's status as a parent holding company or control person, in accordance with Rule 13d-1(b)(1)(ii)(G). The address of CVS Health's principal executive offices is listed as One CVS Drive, Woonsocket, RI 02895. The filing also includes a list of entities under BlackRock's umbrella that beneficially own 5% or greater of the outstanding shares of CVS Health's common stock class. The document was signed by Spencer Fleming, Attorney-In-Fact for BlackRock, Inc., on October 24, 2024.
BlackRock, Inc., a major investment management corporation based in Delaware, has filed an amended Schedule 13G with the Securities and Exchange Commission on September 30, 2024, indicating a significant ownership stake in CVS Health Corporation. The filing reveals that BlackRock now beneficially owns 104,561,659 shares of CVS Health, which represents 8.3% of the company's common stock. This position gives BlackRock sole voting power over 93,976,550 shares and sole dispositive power over the entire 104,561,659 shares held. The filing underscores BlackRock's status as a parent holding company or control person, in accordance with Rule 13d-1(b)(1)(ii)(G). The address of CVS Health's principal executive offices is listed as One CVS Drive, Woonsocket, RI 02895. The filing also includes a list of entities under BlackRock's umbrella that beneficially own 5% or greater of the outstanding shares of CVS Health's common stock class. The document was signed by Spencer Fleming, Attorney-In-Fact for BlackRock, Inc., on October 24, 2024.
貝萊德公司,總部位於特拉華州的一家重要投資管理公司,於2024年9月30日向證券交易委員會提交了修訂後的13G表格,表明其在西維斯健康公司擁有重要的股權。報告顯示,貝萊德現在受益擁有CVS健康公司的104,561,659股股票,佔該公司普通股的8.3%。這一持倉使貝萊德對93,976,550股股票擁有唯一的表決權,對所有持有的104,561,659股股票擁有唯一的實際處置權。該報告強調了貝萊德作爲一家母公司或控制人的地位,符合第13d-1(b)(1)(ii)(G)條的規定。西維斯健康的首席執行官辦公室地址列爲一號西維斯醫藥驅動,郵編02895,Woonsocket。報告還列出了貝萊德旗下的一些實體,這些實體受益擁有西維斯健康普通股類的5%或更多的優先股。該文件由斯賓塞·弗萊明於2024年10月24日代表貝萊德公司簽署。
貝萊德公司,總部位於特拉華州的一家重要投資管理公司,於2024年9月30日向證券交易委員會提交了修訂後的13G表格,表明其在西維斯健康公司擁有重要的股權。報告顯示,貝萊德現在受益擁有CVS健康公司的104,561,659股股票,佔該公司普通股的8.3%。這一持倉使貝萊德對93,976,550股股票擁有唯一的表決權,對所有持有的104,561,659股股票擁有唯一的實際處置權。該報告強調了貝萊德作爲一家母公司或控制人的地位,符合第13d-1(b)(1)(ii)(G)條的規定。西維斯健康的首席執行官辦公室地址列爲一號西維斯醫藥驅動,郵編02895,Woonsocket。報告還列出了貝萊德旗下的一些實體,這些實體受益擁有西維斯健康普通股類的5%或更多的優先股。該文件由斯賓塞·弗萊明於2024年10月24日代表貝萊德公司簽署。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。